Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

BACKGROUND: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death. METHODS: In this controlled, open-label trial comparing a range of possible treatmen...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383595/
https://www.ncbi.nlm.nih.gov/pubmed/32678530
http://dx.doi.org/10.1056/NEJMoa2021436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383595/
https://www.ncbi.nlm.nih.gov/pubmed/32678530
http://dx.doi.org/10.1056/NEJMoa2021436

Ejemplares similares